Application 216167
- Type
- ANDA
- Sponsor
- ZYDUS PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TOPIRAMATE | TOPIRAMATE | CAPSULE, EXTENDED RELEASE;ORAL | 200MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216167-001 | TOPIRAMATE | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 8072bd15b7f6… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | 2023-02-09 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | 2023-02-09 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | 2023-02-09 | 053a50430f4f… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216167-001 | AB1 | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A216167-001 | AB1 | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A216167-001 | AB1 | 1 | 053a50430f4f… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TOPIRAMATE | TOPIRAMATE | NorthStar RxLLC | b5f8da43-6daf-413c-9dcd-363617973738 | 2026-05-20 | Warnings, Adverse reactions | TOPIRAMATE TOPIRAMATE |
| topiramate | TOPIRAMATE | REMEDYREPACK INC. | 5ce65b7f-9215-47a8-a784-f87a810bd7e4 | 2026-05-19 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | REMEDYREPACK INC. | 2f5b1b0b-fd8a-4c4e-a85a-519ca841a0db | 2026-05-19 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Upsher-Smith Laboratories, LLC | 691d276c-9cc1-4d39-828f-0f44d7ef6328 | 2026-05-15 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Vitruvias Therapeutics, Inc. | a9d7c5ef-daf9-4f97-8673-7f4a2007f408 | 2026-05-07 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| TOPIRAMATE | TOPIRAMATE | Glenmark Pharmaceuticals Inc., USA | 54bfabce-1f8a-40ee-8b55-efce8fe6fbf1 | 2026-04-30 | Warnings, Adverse reactions | TOPIRAMATE TOPIRAMATE |
| topiramate | TOPIRAMATE | REMEDYREPACK INC. | 149d20de-f262-4567-aa97-d4d28a1653cb | 2026-04-30 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Coupler LLC | 50b10a3d-883c-8891-e063-6394a90a86a1 | 2026-04-30 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Glenmark Pharmaceuticals Inc., USA | 872927eb-0b61-44bb-9892-3c700b6f2181 | 2026-04-29 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Quallent Pharmaceuticals Health LLC | 9dae6824-6913-42de-b98a-cdcb0d3b4a46 | 2026-04-25 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Zydus Pharmaceuticals USA Inc. | e4886adf-199d-4b19-a4ef-75f8f94cb54e | 2026-04-22 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Ajanta Pharma USA Inc. | b94629e3-ae2e-473e-b2f5-06e32ee19aa9 | 2026-04-20 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Zydus Pharmaceuticals USA Inc. | a5ca2fce-bd2d-40db-b963-e3ec27c8bf23 | 2026-04-16 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Zydus Pharmaceuticals USA Inc. | 67dcdd6e-48bc-418e-a887-805929d83ce0 | 2026-04-15 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Glenmark Pharmaceuticals Inc., USA | 35312f49-decf-428d-bf5f-4215b762ed3c | 2026-04-10 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Unichem Pharmaceuticals (USA), Inc. | 6ee00e82-799d-445e-b658-a9712c49a28e | 2026-04-06 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Advagen Pharma Ltd | 48169bbc-4fb2-4bc4-9bdd-de71bf7722df | 2026-04-03 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Teva Pharmaceuticals, Inc. | 4f20155f-05b9-40ec-af34-3b58aa8d60d4 | 2026-04-01 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Zydus Pharmaceuticals USA Inc. | f72774dd-c7eb-41f9-9837-02baf77cc523 | 2026-03-30 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Lupin Pharmaceuticals, Inc. | e310afcd-1260-434e-a994-34549c789d99 | 2026-03-30 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 73990 | ORIG | 2023-04-14 |